ISSUE: In the recent years, there has been a common effort to identify and measure outcomes that are be meaningful to patient, regulators, payers and industry. With stakeholders placing different value on the same outcome, it may be challenging to reach consensus and standardization. This multi-stakeholder panel will explore if and how can patient, regulators, payers and industry agree on and implement a universal standard set of outcomes by medical condition? OVERVIEW: In a recent NEJM paper, Porter et al highlight that despite the world shifting towards valuing outcomes and performance, measurement of outcomes that matter to patients remains limited. Acknowledging the "patchwork of inconsistent outcomes measures and definitions," authors call upon stakeholders to agree on a minimum set of outcomes for each important medical condition. This multi-stakeholder panel will discuss if and how patient-advocacy groups, industry and payers and regulators can work towards achieving standardization and the opportunities and challenges it raises. Charles Petrie will discuss, from the industry perspective, the feasibility and circumstances that may motivate consistency within and across stakeholders on standard sets of core outcomes by medical condition and how these along with clinician-reported outcomes and administrative data can better support value demonstration. Sheela Upadhyaya will discuss the value of standardization for value appraisal at the HTA level, and how HTA and payers can contribute to these discussion. Bettina Ryll will describe patients’ contributions to the identification, validation and measurement of PRO and what it would take to ensure that outcomes that are meaningful to patients are integrated in decision making processes. After 15 min presentation contrasting the perspectives, panellists will discuss what it would take to accelerate the development and testing of such PROs. Discussions will be followed by 15 minutes of Q&A from the audience. Reference: Standardizing Patient Outcomes Measurement. Porter M et al. NEJM 2016;374:504-506.